Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q1 2024 Earnings Call Transcript May 9, 2024
Recursion Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Chris Gibson: Hi, everybody. I’m Chris Gibson, Co-Founder and CEO of Recursion, and I’m so delighted you’ve joined us today for our Q1 2024 Earnings Call — L(earnings) Call, as we call it. And I want to run through some of the exciting updates from the...
